Cornelis M. Van Tilburg
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Cancer control after pausing treatment with larotrectinib in responding children with sarcoma and a TRK fusion: a plain language summary.
Journal: Future oncology (London, England)
Published: August 19, 2026
Correction: Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis.
Journal: Pharmaceutical medicine
Published: June 18, 2026
Switching Tracks: Activity of Entrectinib After Progression While on Larotrectinib in Neurotrophin Receptor Tyrosine Kinase-Fused Pediatric High-Grade CNS Tumors.
Journal: JCO precision oncology
Published: May 14, 2026
Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experience.
Journal: Genome medicine
Published: February 17, 2026
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas.
Journal: Nature communications
Published: October 09, 2025
Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a PDGFRA inhibitor trial.
Journal: Neuro-oncology advances
Published: August 13, 2025
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM.
Journal: Acta neuropathologica
Published: May 29, 2025
Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325].
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 13, 2025
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 03, 2025
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 14, 2025
Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targets.
Journal: Neuro-oncology advances
Published: February 03, 2025
Last Updated: 09/26/2026